Used in research and development for treating diseases involving abnormal blood vessel formation, particularly in age-related macular degeneration and certain cancers. It works by neutralizing VEGF-B, a protein involved in vascular maintenance and lipid metabolism, helping to study its role in pathological conditions. This antibody serves as a tool to investigate therapeutic strategies targeting the VEGF-B pathway, especially in metabolic and cardiovascular diseases.